… finding safe and effective vaccines. By July 2021 there were 184 COVID-19 vaccine candidates
in pre-clinical development, 105 in clinical development, and 18 vaccines approved for …

… have raised more challenges, both for the vaccine developers as well as the … vaccines with
examples of COVID-19 vaccines, their rapid development compared to the traditional vaccine…

… derived from past development of RSV, dengue, SARS and MERS vaccines, we offer the …
a safe and effective COVID-19 vaccine. First, the safety of COVID-19 vaccine candidates should …

… novel and traditional approaches for COVID-19 vaccine development including inactivated,
… induced by vaccines has shown comparative immunogenicity profiles of various vaccines in …

… against COVID-19. To facilitate this effort, we have developed and are continuously … of
COVID-19 vaccine development activity. Our landscape database includes vaccine development …

… of the COVID-19 pandemic is driving evaluation of nextgeneration vaccine technology
platforms through novel paradigms to accelerate development, and the first COVID-19 vaccine …

… However, some viral vector or mRNA vaccines may be associated with complications …
COVID-19 vaccines. Here, we systemically assess the safety and efficacy of COVID-19 vaccines, …

… Currently, more than 115 vaccine candidates have been … Most of those vaccine candidates
are developed based on the … for the development of a safe and effective COVID-19 vaccine. …

… There are ways to mitigate the risks of vaccine-enhanced disease syndromes informed by
prior work on RSV vaccines that should be considered for COVID-19 vaccine development (15…

… development The progression of COVID-19 vaccine candidates into clinical development
is … Some of the most important considerations for clinical development of COVID-19 vaccine …